Security key
28623U101
Elevation Oncology, Inc. - Common Stock, par value $0.0001 per share (ELEV)
CUSIP: 28623U101
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 62,337,402
- Total 13F shares
- 14,278,557
- Share change
- -1,090,015
- Total reported value
- $16,134,000
- Price per share
- $1.13
- Number of holders
- 21
- Value change
- -$1,527,236
- Number of buys
- 5
- Number of sells
- 9
Report period
Q3 2022
Institutions
21
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 28623U101
Recent filing periods:
Top shareholders of ELEV - Elevation Oncology, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Elevation Oncology, Inc. - Common Stock, par value $0.0001 per share (ELEV) as of Q3 2022
As of 30 Sep 2022,
Elevation Oncology, Inc. - Common Stock, par value $0.0001 per share (ELEV) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,278,557 shares.
The largest 10 holders included
Aisling Capital Management LP, Qiming U.S. Ventures Management, LLC, BVF INC/IL, Cormorant Asset Management, LP, venBio Partners LLC, Samsara BioCapital, LLC, TCG Crossover Management, LLC, Sio Capital Management, LLC, VANGUARD GROUP INC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
24
Q3 2022 holders
21
Holder diff
-3
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.